V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20214764 | 20155351 | 1.6 | 77.9 | null | 2022-04-01 | 2022-04-18 | Carboplatin + Etoposide IV 3 day | 02 | null | CARBOPLATIN + ETOPOSIDE | 101579208 |
| 20214766 | 20155353 | 1.76 | 56.7 | null | 2021-05-29 | 2021-06-09 | Panitumumab | 02 | null | PANITUMUMAB | 100691289 |
| 20214767 | 20155354 | 1.71 | 75.4 | Curative (C) | 2016-12-12 | 2016-12-19 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 100666150 |
| 20214770 | 20155356 | 1.78 | 53 | null | 2022-03-24 | 2022-03-29 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101565793 |
| 20214771 | 20155357 | 1.79 | 71.8 | null | null | null | NIVOLUMAB | 02 | null | NIVOLUMAB | 100555278 |
| 20214772 | 20155358 | 1.75 | 62.7 | Palliative (P) | null | 2020-11-10 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100270949 |
| 20214773 | 20155359 | 1.47 | 47.65 | Palliative (P) | 2019-02-02 | 2019-02-13 | null | N | N | ECX | 101367434 |
| 20214774 | 20155360 | 1.84 | 103.1 | Curative (C) | 2020-02-04 | 2020-02-11 | Panitumumab | 02 | N | PANITUMUMAB | 100534976 |
| 20214789 | 20155361 | null | null | null | 2018-04-06 | 2018-04-07 | ECX | 02 | null | ECX | 100123714 |
| 20214792 | 20155362 | 1.57 | 73.5 | null | 2018-04-24 | 2018-05-18 | Capecitabine 5days + RT | N | null | CAPECITABINE + RT | 101407417 |
| 20214793 | 20155363 | 1.64 | 48.7 | Palliative (P) | 2020-12-30 | 2021-01-23 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100041433 |
| 20214806 | 20155364 | 1.77 | 84 | Palliative (P) | 2020-12-21 | 2020-12-24 | EOX | 01 | N | TRIAL | 100350957 |
| 20214819 | 20155365 | 1.65 | 72.95 | null | null | 2019-11-15 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100479952 |
| 20214820 | 20155366 | 1.69 | 70.1 | null | 2018-12-16 | 2018-12-16 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101487856 |
| 20214822 | 20155367 | 1.88 | 82.5 | Palliative (P) | 2019-11-09 | 2019-11-18 | Trial Unspecified | N | N | TRIAL | 101704048 |
| 20214824 | 20155368 | 1.5 | 76 | Palliative (P) | null | 2018-08-23 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101510025 |
| 20214825 | 20155369 | 1.73 | 88.8 | Adjuvant (A) | 2021-03-03 | 2021-03-03 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100335688 |
| 20214826 | 20155370 | 1.64 | 83 | Palliative (P) | null | 2020-05-29 | EOX | N | N | EOX | 100918669 |
| 20214830 | 20155371 | 1.67 | 95.3 | Curative (C) | 2019-09-26 | 2019-10-11 | Cetuximab + FLUOROURACIL + OXALIPLATIN | N | Y | EOX | 100315596 |
| 20214831 | 20155372 | 1.59 | 63.8 | Palliative (P) | 2018-09-16 | 2018-09-16 | EOX | null | N | CETUXIMAB + IRINOTECAN + MDG | 100607024 |
| 20214833 | 20155373 | 1.67 | 86.6 | Palliative (P) | 2017-09-05 | 2017-10-29 | EOX | N | N | SORAFENIB | 100260972 |
| 20214834 | 20155374 | 1.6 | 0 | Palliative (P) | 2020-01-25 | 2020-03-31 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | OXALIPLATIN + RALTITREXED | 100900742 |
| 20214835 | 20155375 | 1.81 | 66.1 | Palliative (P) | 2018-07-03 | 2018-07-11 | EOX | N | N | EOX | 101479784 |
| 20214836 | 20155376 | 1.81 | 80 | null | 2019-08-13 | 2019-12-01 | EOX | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101491028 |
| 20214839 | 20155377 | 1.83 | 76.7 | Palliative (P) | null | 2017-05-24 | Capecitabine 35days + RT | 02 | null | CAPECITABINE + RT | 100794594 |
| 20214840 | 20155378 | 1.8 | 91.4 | Palliative (P) | 2017-02-02 | 2017-04-22 | IRINOTECAN + MDG + PANITUMUMAB | 2 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100191706 |
| 20214843 | 20155379 | 1.71 | 97.3 | Palliative (P) | null | 2015-03-15 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100155282 |
| 20214844 | 20155380 | 1.72 | 83.7 | Palliative (P) | 2018-12-20 | 2018-12-20 | EOX | 99 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101295846 |
| 20214847 | 20155381 | 1.75 | 0 | null | 2019-02-16 | 2019-03-02 | Sorafenib | N | null | SORAFENIB | 101719580 |
| 20214848 | 20155382 | 1.6 | 63.6 | Palliative (P) | 2020-02-12 | 2020-02-19 | EOX | N | N | EOX | 100413053 |
| 20214851 | 20155383 | 1.69 | 84.9 | Palliative (P) | null | 2021-03-04 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100459835 |
| 20214852 | 20155384 | 1.75 | 86.4 | null | 2016-11-24 | 2016-12-16 | Trial Unspecified | N | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101194972 |
| 20214853 | 20155385 | 1.76 | 73.8 | Palliative (P) | 2016-12-04 | 2018-11-26 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101144697 |
| 20214857 | 20155386 | 1.61 | 63 | Adjuvant (A) | 2018-02-13 | 2018-02-21 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101468789 |
| 20214859 | 20155387 | 1.69 | 76.3 | Palliative (P) | 2021-10-23 | 2021-10-25 | EOX | 02 | N | SORAFENIB | 100718005 |
| 20214862 | 20155388 | 1.6 | 50.7 | Neo-adjuvant (N) | 2019-06-25 | 2019-07-20 | Capecitabine 35days + RT | 2 | N | CAPECITABINE + RT | 100004614 |
| 20214868 | 20155389 | 1.66 | 102.6 | Palliative (P) | 2018-08-18 | 2018-08-19 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 101141735 |
| 20214869 | 20155390 | 1.79 | 61 | Palliative (P) | 2018-10-01 | 2018-10-01 | EOX | N | N | EOX | 101475991 |
| 20214876 | 20155391 | 1.74 | 40.6 | Palliative (P) | 2018-10-28 | 2018-10-28 | Sorafenib | 02 | N | SORAFENIB | 100019592 |
| 20214877 | 20155392 | 1.7 | 71.1 | Palliative (P) | null | 2019-12-11 | IRINOTECAN + MDG + PANITUMUMAB | 2 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100263639 |
| 20214881 | 20155393 | 1.75 | 92.8 | Palliative (P) | 2016-11-11 | 2017-02-28 | IRINOTECAN + MDG + PANITUMUMAB | N | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100896970 |
| 20214882 | 20155394 | 1.6 | 70.1 | Palliative (P) | null | 2018-09-19 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100490931 |
| 20214891 | 20155395 | 1.84 | 80.4 | null | 2019-01-09 | 2019-01-20 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 101751699 |
| 20214893 | 20155396 | 1.74 | 113.2 | null | 2016-09-17 | 2016-12-23 | EOX | 2 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100347945 |
| 20214895 | 20155397 | 1.6 | 70 | Curative (C) | 2018-06-29 | 2018-07-20 | EOX | 2 | Y | EOX | 101279291 |
| 20214896 | 20155398 | 1.64 | 87.7 | Palliative (P) | 2020-06-18 | 2020-10-21 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 99 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100471720 |
| 20214897 | 20155399 | 1.6 | 68.3 | Adjuvant (A) | 2019-08-15 | 2019-08-23 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100016782 |
| 20214898 | 20155400 | 1.66 | 52 | Palliative (P) | 2019-07-27 | 2019-07-29 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100108905 |
| 20214900 | 20155401 | 1.84 | 102.6 | Curative (C) | 2020-02-15 | 2020-05-06 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100383056 |
| 20214901 | 20155402 | 1.76 | 74 | null | null | 2016-08-29 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 2 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100939900 |